EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia ,

ISSN 2394-3211

Impact Factor: 7.065

ICV - 79.57

Abstract

CORRELATION BETWEEN APOB/APOAI RATIO AND DYSLIPIDEMIA IN INDIAN CHRONIC HEART FAILURE PATIENTS

Dr. Rohit Sane, Dr. Gurudatta Amin, Dr. Snehal Dongre and *Dr. Rahul Mandole

ABSTRACT

Background: Ratio of apolipoprotein-B (apoB) and apolipoprotein-AI (apoAI) is found to be a strong predictor for cardiovascular diseases, including chronic heart failure (CHF). The debatable relationship between apoB/apoAI and other lipid parameters has not been explored in Indian CHF patients. Hence, we evaluated the correlation between apoB/apoAI and lipid parameters in Indian CHF patients. Methodology: This retrospective study was conducted using data of CHF patients who visited Madhavbaug clinics in India, between July-December 2018. The parameters assessed under lipid profile on the collected venous blood from patients included serum total cholesterol (TC), serum triglycerides (TG), serum low-density lipoproteins (LDL), serum high-density lipoproteins (HDL), serum very-low density lipoproteins (VLDL), serum apoAI and apoB. The apoB/apoAI ratio was calculated and then correlation with other lipid parameters was assessed using Pearson correlation coefficient test. Results: Of the 147 included CHF patients, majority were males (N=109,74.15%) with a mean age of 59.15+10.28 years. The correlation coefficient (R) was found to be 0.41 and 0.24 respectively between apoB/apoAI ratio and serum TC as well as apoB/apoAI ratio and serum TG, which were statistically significant (p<0.05). Correlation between apoB/apoAI ratio and serum HDL was found to be indicative of inverse correlation, but this was not significant statistically (p>0.05). Correlation between apoB/apoAI ratio and serum LDL (R=0.39), serum VLDL (R=0.24) as well as LDL/HDL ratio (R=0.25) were all found to be positive and these findings were statistically significant (p<0.05). Conclusion: Raised apoB/apoAI ratio was found to be significantly correlated with dyslipidemia in the Indian CHF patients.

Keywords: Dyslipidemia, Apolipoprotein B, Apolipoprotein AI, Lipoproteins, Chronic Heart Failure.

[Full Text Article] [Download Certificate]